CANTHARIDIN | N212905 | VERRICA PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Verrica Pharmaceuticals FDA-2023-P-4510 · 4 docket documents Verrica Pharmaceuticals Inc. filed this citizen petition on October 11, 2023, requesting that the FDA remove cantharidin from the 503A Bulks List under 21 C.F.R. § 216.23, remove it from 503B Category 1 under the Interim Policy on Compounding Bulk Drug Substances Under 503B, and issue a final notice | Other | 2023-10-13 | Partially Denied | Verrica Pharmaceuticals |
Citizen Petition From Hyman Phelps and McNamara PC FDA-2014-P-0367 · 4 docket documents Hyman, Phelps & McNamara PC, on behalf of a client, submitted this petition requesting that the FDA exclude cantharidin from the list of bulk drug substances that may be used for compounding under section 503B of the Federal Food, Drug, and Cosmetic Act and instead designate it as a drug product pre | Other | 2014-03-31 | Open | Hyman Phelps and McNamara PC |
Source: Regulations.gov. FDA citizen petitions matched by application number.